Insights from 2023 EHA® Annual Meeting

 

Benign Hematology
14:32

Insights from 2023 EHA® Annual Meeting

EHA® 2023 Insights: "Preliminary Results From the Ph1/2 RUBY Trial of EDIT-301 in Patients With Severe Sickle Cell Disease Using Highly Specific and Efficient ASCAS12A Enzyme"

FEATURING Rabi Hanna
  • 188 views
  • June 23, 2023
  • 2
07:48

Insights from 2023 EHA® Annual Meeting

EHA® 2023 Insights: "ATLAS-PPX, A Ph3 Study of Fitusiran in People With Hemophilia A or B Who Have Switched From Prior Factor or Bypassing Agent Prophylaxis"

FEATURING Guy Young
  • 63 views
  • June 14, 2023